New analyses from the Norwegian randomized controlled trial CARBFUNC show that more than doubling saturated fat intake over a two-year period can promote favorable changes in several cardiovascular risk markers, without increasing apoB, the main suspected risk factor. ApoB is a protein found in the particles that transport cholesterol in the blood and can be used to assess the risk of cardiovascular disease.
Impact of Low-Carb, High-Saturated Fat Diet on Cholesterol Levels: Findings from a Two-Year Norwegian Trial
A two-year trial in Norway indicates that a low-carb diet high in saturated fat can lead to positive changes in cardiovascular risk markers without raising apoB levels. This research may influence dietary recommendations and health policies in Iran, where cardiovascular diseases are a significant health concern. Understanding dietary impacts on health is crucial for improving public health strategies in the country.
👥 Key Players
📰 What Happened
A two-year Norwegian trial found that a low-carb, high-saturated fat diet can improve cardiovascular risk markers without increasing apoB levels, a key risk factor for heart disease.
- The trial showed favorable changes in cardiovascular risk markers.
- ApoB levels, which are linked to heart disease risk, did not increase.
💡 Why It Matters
📚 Background
Cardiovascular diseases are a leading cause of death globally, and dietary factors play a significant role in managing health risks.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%